Maze Therapeutics, Inc.

MAZE·NASDAQ·$26.35Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/25/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report10/16/26 8-KCurrent report08/17/26 8-KCurrent report08/11/26 8-KCurrent report06/10/26 8-KCurrent report05/22/26

Prospectuses and Registrations

POS AMPost-effective amendment05/12/26 424B5Prospectus supplement04/22/26 S-3ASRAutomatic shelf registration02/04/26 S-8Registration of securities for employees02/04/26 424B3Prospectus11/06/25

Proxies

DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26

Ownership

Form 4Insider transaction10/30/26 144Proposed sale of securities10/29/26 Form 4Insider transaction10/02/26 Form 4Insider transaction10/02/26 144Proposed sale of securities10/01/26

Other

EFFECTRequest for effectiveness05/13/26 ARSAnnual report to shareholders04/28/26 SEC STAFF LETTERSEC staff letter02/06/25 CERTCEO/CFO certification01/30/25 CORRESPCorrespondence with the SEC01/30/25